PLAINS GP HOLDINGS LP current report, 10 November 2014

Business Context and Reporting Period

This Form 8-K filing by Plains GP Holdings, L.P. (the "Partnership") reports on events occurring on November 10, 2014. The filing details the entry into a Material Definitive Agreement regarding a secondary offering of Class A shares.

Key Financial Metrics

The filing describes a capital transaction rather than operational financial results. Key transaction metrics include:

  • Shares Sold: 60,000,000 Class A shares initially, with an additional 9,000,000 shares purchased upon full exercise of the underwriters' option.
  • Total Shares: 69,000,000 Class A shares.
  • Price to Public: $25.00 per share.
  • Net Proceeds to Seller: $24.4375 per share (net of underwriting discounts).
  • Proceeds to Partnership: The Partnership will not receive any proceeds from this sale.

Operational metrics such as revenue, profit, cash flow, margins, debt, and liquidity are not provided in this filing.

Material Changes

The primary material change is the execution of an Underwriting Agreement with J.P. Morgan Securities LLC and Citigroup Global Markets Inc. The transaction involves the sale of shares by Oxy Holding Company (Pipeline), Inc. (the "Selling Shareholder"). The underwriters exercised their option to purchase the additional 9,000,000 shares on November 11, 2014. Closing was expected on November 14, 2014.

Outlook, Risks, and Management Commentary

Management Commentary: The Partnership will pay certain expenses associated with the sale, excluding underwriting discounts and commissions. The Partnership and the Selling Shareholder have agreed to indemnify the Underwriters against certain liabilities.

Risks and Contingencies: The closing is subject to the satisfaction of customary closing conditions. The filing references customary representations, warranties, and termination provisions within the Underwriting Agreement.

Investor Verification Checklist

  • Verify the final closing date and confirmation of the full exercise of the 9,000,000 share option.
  • Confirm the total gross proceeds received by the Selling Shareholder versus the net amount after fees.
  • Review the specific expenses the Partnership is obligated to pay regarding this transaction.
  • Check subsequent filings for any changes to the ownership structure of the Partnership resulting from this secondary offering.